Copyright Reports & Markets. All rights reserved.

Global Diabetes Drug Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Diabetes Drug Market Overview

      • 1.1 Product Overview and Scope of Diabetes Drug
      • 1.2 Diabetes Drug Segment by Type
        • 1.2.1 Global Diabetes Drug Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Insulin
        • 1.2.3 Sensitizers
        • 1.2.4 SGLT-2 Inhibitors
        • 1.2.5 Alpha-glucosidase Inhibitors
        • 1.2.6 Secretagogues
        • 1.2.7 Peptide Analogs
        • 1.2.8 Others
      • 1.3 Diabetes Drug Segment by Application
        • 1.3.1 Diabetes Drug Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Diabetes Drug Market by Region
        • 1.4.1 Global Diabetes Drug Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Diabetes Drug Market Size
        • 1.5.1 Global Diabetes Drug Revenue (2014-2025)
        • 1.5.2 Global Diabetes Drug Production (2014-2025)

      2 Global Diabetes Drug Market Competition by Manufacturers

      • 2.1 Global Diabetes Drug Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Diabetes Drug Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Diabetes Drug Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Diabetes Drug Production Sites, Area Served, Product Types
      • 2.5 Diabetes Drug Market Competitive Situation and Trends
        • 2.5.1 Diabetes Drug Market Concentration Rate
        • 2.5.2 Diabetes Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Diabetes Drug Production Market Share by Regions

      • 3.1 Global Diabetes Drug Production Market Share by Regions
      • 3.2 Global Diabetes Drug Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Diabetes Drug Production
        • 3.4.1 North America Diabetes Drug Production Growth Rate (2014-2019)
        • 3.4.2 North America Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Diabetes Drug Production
        • 3.5.1 Europe Diabetes Drug Production Growth Rate (2014-2019)
        • 3.5.2 Europe Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Diabetes Drug Production (2014-2019)
        • 3.6.1 China Diabetes Drug Production Growth Rate (2014-2019)
        • 3.6.2 China Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Diabetes Drug Production (2014-2019)
        • 3.7.1 Japan Diabetes Drug Production Growth Rate (2014-2019)
        • 3.7.2 Japan Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Diabetes Drug Consumption by Regions

      • 4.1 Global Diabetes Drug Consumption by Regions
      • 4.2 North America Diabetes Drug Consumption (2014-2019)
      • 4.3 Europe Diabetes Drug Consumption (2014-2019)
      • 4.4 China Diabetes Drug Consumption (2014-2019)
      • 4.5 Japan Diabetes Drug Consumption (2014-2019)

      5 Global Diabetes Drug Production, Revenue, Price Trend by Type

      • 5.1 Global Diabetes Drug Production Market Share by Type (2014-2019)
      • 5.2 Global Diabetes Drug Revenue Market Share by Type (2014-2019)
      • 5.3 Global Diabetes Drug Price by Type (2014-2019)
      • 5.4 Global Diabetes Drug Production Growth by Type (2014-2019)

      6 Global Diabetes Drug Market Analysis by Applications

      • 6.1 Global Diabetes Drug Consumption Market Share by Application (2014-2019)
      • 6.2 Global Diabetes Drug Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Diabetes Drug Business

      • 7.1 Eli Lilly
        • 7.1.1 Eli Lilly Diabetes Drug Production Sites and Area Served
        • 7.1.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.1.3 Eli Lilly Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Novo Nordisk
        • 7.2.1 Novo Nordisk Diabetes Drug Production Sites and Area Served
        • 7.2.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.2.3 Novo Nordisk Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Abbott
        • 7.3.1 Abbott Diabetes Drug Production Sites and Area Served
        • 7.3.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.3.3 Abbott Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 AstraZeneca
        • 7.4.1 AstraZeneca Diabetes Drug Production Sites and Area Served
        • 7.4.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.4.3 AstraZeneca Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Biocon
        • 7.5.1 Biocon Diabetes Drug Production Sites and Area Served
        • 7.5.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.5.3 Biocon Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Sunpharma
        • 7.6.1 Sunpharma Diabetes Drug Production Sites and Area Served
        • 7.6.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.6.3 Sunpharma Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanofi
        • 7.7.1 Sanofi Diabetes Drug Production Sites and Area Served
        • 7.7.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.7.3 Sanofi Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Novartis
        • 7.8.1 Novartis Diabetes Drug Production Sites and Area Served
        • 7.8.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.8.3 Novartis Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Merck
        • 7.9.1 Merck Diabetes Drug Production Sites and Area Served
        • 7.9.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.9.3 Merck Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Pfizer
        • 7.10.1 Pfizer Diabetes Drug Production Sites and Area Served
        • 7.10.2 Diabetes Drug Product Introduction, Application and Specification
        • 7.10.3 Pfizer Diabetes Drug Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Daiichi Sankyo
      • 7.12 Boehringer Ingelheim
      • 7.13 Akros Pharma
      • 7.14 Amgen
      • 7.15 Adocia
      • 7.16 Peptron
      • 7.17 Takeda

      8 Diabetes Drug Manufacturing Cost Analysis

      • 8.1 Diabetes Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Diabetes Drug
      • 8.4 Diabetes Drug Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Diabetes Drug Distributors List
      • 9.3 Diabetes Drug Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Diabetes Drug Market Forecast

      • 11.1 Global Diabetes Drug Production, Revenue Forecast
        • 11.1.1 Global Diabetes Drug Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Diabetes Drug Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Diabetes Drug Price and Trend Forecast (2019-2025)
      • 11.2 Global Diabetes Drug Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Diabetes Drug Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Diabetes Drug Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Diabetes Drug Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Diabetes Drug Production, Revenue Forecast (2019-2025)
      • 11.3 Global Diabetes Drug Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Diabetes Drug Consumption Forecast (2019-2025)
        • 11.3.2 Europe Diabetes Drug Consumption Forecast (2019-2025)
        • 11.3.3 China Diabetes Drug Consumption Forecast (2019-2025)
        • 11.3.4 Japan Diabetes Drug Consumption Forecast (2019-2025)
      • 11.4 Global Diabetes Drug Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Diabetes Drug Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two type of diabetes namely type-1 diabetes and type-2 diabetes. During last decade there is a tremendous increase in the number of diabetic population.
        The analysis shows human insulins and analogues dominated the antidiabetics market in 2017.

        The global Diabetes Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Diabetes Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diabetes Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Eli Lilly
        Novo Nordisk
        Abbott
        AstraZeneca
        Biocon
        Sunpharma
        Sanofi
        Novartis
        Merck
        Pfizer
        Daiichi Sankyo
        Boehringer Ingelheim
        Akros Pharma
        Amgen
        Adocia
        Peptron
        Takeda

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Insulin
        Sensitizers
        SGLT-2 Inhibitors
        Alpha-glucosidase Inhibitors
        Secretagogues
        Peptide Analogs
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now